Spanish Life Sciences Stock News

Guidance revision and earnings snapshot for Amadeus IT Group Amadeus IT Group (BME:AMS) recently updated its 2026 guidance and reported second quarter and half year results, giving you fresh information on revenue trends, profitability and the impact of its cost containment efforts. See our latest analysis for Amadeus IT Group. The updated 2026 guidance and recent earnings come as Amadeus IT Group trades at €58.04, with a 30 day share price return of 14.39% and a year to date share price...

Why Prosegur Compañía de Seguridad Stock Is in Focus After Half Year Results Prosegur Compañía de Seguridad (BME:PSG) is drawing fresh attention after reporting half year 2026 results on 31 July, with both sales and net income higher than the same period a year earlier. See our latest analysis for Prosegur Compañía de Seguridad. The earnings release appears to have kept interest in Prosegur Compañía de Seguridad steady, with the share price at €2.935, a 30 day share price return of 4.82%, and...

Spain’s sweeping migrant amnesty, which gives more than 1 million workers legal status, is shaking up expectations for labor intensive sectors just as investors are watching Europe’s political mood closely. That mix of fresh labor supply and policy risk can reshape costs, margins, and growth plans. This article breaks down how that story connects to Spanish stocks and reveals 3 companies directly exposed to this news. The stocks highlighted below are a sample of how Spain’s labor intensive...

CaixaBank earnings spark fresh attention on the stock CaixaBank (BME:CABK) drew fresh investor attention after reporting second quarter 2026 net income of €1,631 million and first half net income of €3,203 million, both above the prior year figures. See our latest analysis for CaixaBank. The solid earnings update comes after a strong run in CaixaBank's stock, with a 90 day share price return of 21.56% helping lift the share price to €12.94 and contributing to a very large 5 year total...

Neinor Homes (BME:HOME) reaffirmed its 2026 earnings guidance on 28 July 2026, stating that it remains on track to achieve net income of €120 million to €140 million, adjusted for one-off items. See our latest analysis for Neinor Homes. Despite reaffirmed 2026 guidance, Neinor Homes shares have come under pressure, with the share price down 7.22% over the past month and 18.96% year to date. However, the 3 year total shareholder return of 155.22% and 5 year total shareholder return of 103.10%...

A lackluster earnings announcement from Prim, S.A. ( BME:PRM ) last week didn't sink the stock price. We think that...

Pharma Mar (BME:PHM) is in focus after reporting first half 2026 net income of €0.561 million compared with €19.42 million a year earlier, with earnings per share from continuing operations also sharply lower. See our latest analysis for Pharma Mar. Pharma Mar's latest earnings update arrived after a weak patch for the stock, with a 90 day share price return down 21.21% and a 30 day share price return down 3.98%. However, the €78.4 share price still sits above levels implied by its 140.97%...

Inmobiliaria del Sur, S.A. ( BME:ISUR ) announced strong profits, but the stock was stagnant. Our analysis suggests...

Cellnex Telecom (BME:CLNX) drew fresh attention after reporting half year 2026 results on 30 July, with revenue of €2,208.75 million and a reduced net loss of €97.3 million compared with last year. See our latest analysis for Cellnex Telecom. The earnings update appears to have supported a short burst of interest in Cellnex Telecom, with a 1-day share price return of 2.84% and a 1-month share price return of 9.06%. However, the 1-year total shareholder return is still down 5.76%, which points...

A lackluster earnings announcement from Inmocemento, S.A. ( BME:IMC ) last week didn't sink the stock price. We think...

The European stock markets have shown resilience, with the pan-European STOXX Europe 600 Index reaching new highs amid strong corporate earnings and renewed interest in AI-related stocks. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their potential for significant returns. Although the term 'penny stock' might seem outdated, these investments can still uncover hidden value when focused on companies with solid...

Arteche Lantegi Elkartea (BME:ART) has drawn fresh attention after reporting half year 2026 results with sales of €281.85 million and net income of €30.56 million, both higher than the prior period. See our latest analysis for Arteche Lantegi Elkartea. The latest half year earnings have arrived after a sharp share price pullback, with Arteche Lantegi Elkartea showing a 30 day share price return down 11.46% and a 90 day share price return down 35.00%, yet a year to date share price gain of...

Redeia Corporación stock reaction to fresh 2026 guidance and half year numbers Redeia Corporación (BME:RED) has been in focus after releasing half year 2026 results, alongside guidance that points to net profit above €510 million and gives investors updated information on the company’s earnings profile. See our latest analysis for Redeia Corporación. At a share price of €15.45, Redeia Corporación has seen a 90 day share price return of 5.97%, while the 3 year total shareholder return of...

The market for Azkoyen, S.A.'s ( BME:AZK ) shares didn't move much after it posted weak earnings recently. We think...

The recent earnings posted by Deoleo, S.A. ( BME:OLE ) were solid, but the stock didn't move as much as we expected...

Fluidra (BME:FDR) has drawn renewed attention to its stock after announcing a share repurchase program of up to €40 million, alongside half-year 2026 results that report higher revenue and lower net income. See our latest analysis for Fluidra. Despite the new buyback plan and Fluidra’s latest half year results, recent momentum is mixed, with a 7 day share price return of 5.3%, a year to date share price return that is down 15.5%, and a 1 year total shareholder return that is down 8.4%. If...

Grifols (BME:GRF) has been in focus after its half year 2026 report showed sales of €3,574 million compared to €3,677 million a year earlier, while net income reached €227 million against €177 million. See our latest analysis for Grifols. The recent half year 2026 report appears to have been the key driver behind Grifols’ 13.11% 1 month share price return and 12.41% 3 month share price return, although the total shareholder return over 1 and 5 years remains sharply lower. This suggests...

Amadeus IT Group (BME:AMS) has come into focus after revising its 2026 earnings guidance, with expectations for group revenue growth now framed in a mid to high single digit range. See our latest analysis for Amadeus IT Group. The revised 2026 outlook arrives after a period where Amadeus IT Group’s recent momentum has picked up, with a 1 month share price return of 10.57% and a 3 month share price return of 12.59%. However, the year to date share price return is down 9.92% and the 1 year...

When extreme heat, drought and wildfires start to squeeze olive groves and crop fields across Europe, the impact does not stop at the farm gate. It can change pricing power, cost pressures and risk profiles for listed agricultural producers. This article looks at how that backdrop links to three stocks exposed to the latest weather driven shocks in olive oil and key food crops. You see which companies could stand to benefit from tighter supply and where operational resilience really matters,...

Enagás, S.A. reported half-year 2026 results with sales of €444.63 million, net income of €126.91 million and basic earnings per share from continuing operations of €0.49, all lower than the same period a year earlier. The sharper decline in net income and earnings per share compared with the modest reduction in sales suggests pressure on profitability rather than simply weaker top-line performance. We will now examine how this earnings contraction, particularly the disproportionate fall in...

Q2 2026 earnings highlight Banco de Sabadell stock Banco de Sabadell (BME:SAB) reported its second quarter 2026 earnings with net interest income of €902 million and net income of €624 million, giving investors fresh insight into the bank’s recent performance. See our latest analysis for Banco de Sabadell. Despite some recent volatility around the Q2 2026 results and the board decision to cancel treasury shares from its buyback programme, Banco de Sabadell’s share price has gained 6.81% over...

Metrovacesa S.A. has reported results for the half year ended June 30, 2026, posting net income of €17.84 million versus a net loss of €15.49 million a year earlier, with basic and diluted earnings per share from continuing operations rising to €0.1176 from a loss of €0.1022. This return to profitability marks a significant shift in the company’s recent financial performance and offers fresh context for assessing its longer-term earnings profile. We’ll now examine how Metrovacesa’s move back...

In the past quarter ended June 30, 2026, CaixaBank, S.A. reported net income of €1,631 million, up from €1,482 million a year earlier, and first-half net income of €3,203 million compared with €2,951 million in the prior-year period. This consistent year-on-year increase in quarterly and half-year net income highlights CaixaBank’s ability to grow earnings across different reporting horizons. Next, we will examine how CaixaBank’s higher second-quarter net income shapes its investment...

Banco Santander (BME:SAN) is back in focus after its half year 2026 earnings, reporting net income of €8,973 million and disclosing that it holds shares in leading Bitcoin and Ethereum exchange traded funds. See our latest analysis for Banco Santander. The recent disclosure of cryptocurrency ETF holdings and the half year 2026 net income update come after a strong run in Banco Santander’s stock, with an 18.67% 90 day share price return and a five year total shareholder return of 341.90%...